Resection esophageal

Many surgeons consider lymphatic involvement in resectable esophageal adenocarcinoma equivalent to systemic disease therefore, esophageal resection in these patients is essentially palliative. For this reason, wide peritumoral resection and aggressive lymph node dissection is not performed. Most smgeons would perform a... 

Body temperature Malignant hyperthermia occurred 3 hours after the start of an operation for esophageal resection in an 82-year-old man after anesthesia induced with propofol and suxamethonium and maintained with sevoflurane [6 ]. Masseter spasm was not a feature. End-tidal CO2 rose to 55 mmHg and body temperature exceeded 39.0°C. The patient responded promptly to dantrolene. Reports of malignant hyperthermia in patients over the age of 80 years are unusual. Both suxamethonium and sevofiur-ane are potent triggers. 

Nakamura N, Ueda T, Ishikawa R, Tasaka Y, Fukuuchi K, Sato N. Malignant hyperthermia developing during esophageal resection in an 82-year-old man. J Anesth 2008 22(4) 464—6. 

Subramanian A, Berbari EF, Brown MJ, AUen MS, Alsara A, Kor DJ. Plasma transfusion is associated with postoperative infectious complications following esophageal resection surgery a retrospective cohort study. J Cardiothorac Vase Anesth 2012 26(4) 569-74. 

Dimick JB, Pronovost PJ, Heitmiller RF, et al. Intensive care unit physician staffing is associated with decreased length of stay, hospital cost, and complications after esophageal resection. Crit Care Med 2001 29(4) 753-758. 

The use of 5-FU in combination with radiotherapy has shown improved survival in various malignancies including unresectable pancreatic cancer, resectable pancreatic cancer, Dukes B2 and C rectal cancer, esophageal cancer, and hepatobiliary cancer (Table 2). Similarly, 5-FU with concurrent radiation has also been used for organ preservation in different tumors involving bladder cancer, anal cancer, and laryngeal cancer (Table 3). 

Vanderbilt University Medical Center has recently completed accruing patients to a Phase II study of neoadjuvant chemoradiation, which consists of preoperative paclitaxel (175 mg/m2,3-h infusion) followed by cisplatin 75 mg/m2 d 1 and 21. Concurrent radiation was given to a total dose of 3000 cGy, in 200 cGy/fraction. Patients who are resectable go on to surgery 4 wk after completion of chemoradiation, whereas those who are unresectable (i.e., cervical esophageal cancer) continue to a total dose of 60 Gy without treatment interruptions. One month following surgery, patients receive two cycles (q 21-28 d) of postoperative chemotherapy, which consists of paclitaxel 175 mg/m2 over 3 h d 1,5-FU 350 mg/m2, d 1-3, and leucovorin 300 mg d 1-3. Preliminary analysis of this... 

Hoff SJ, Stewart JR, Sawyers JL, et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993 56(2) 282-286. 

Esophageal adenocarcinomas do not appear to be as responsive [171]. Ajani et al. [172] have studies neoadjuvant EAP (VP-16, doxorubicin, and cisplatin) for patients with adenocarcinomas of the distal esophagus and gastroesophageal junction and observed a 42% response rate 78% of treated patients underwent curative resection and overall median survival was 23 months. 

Radical resection of oropharyngeal region Esophageal reconstruction Gastrectomy Intestinal resection Pancreatectomy Radiation Head and neck Abdomen and pelvis... 

More than 10000 Americans will develop esophageal cancer this year with an overall 5-year survival rate of 4-7% and a 1 year survival of 20% [6,7]. Surgical intervention is able to provide 40% of patients with palliation provided resection can be performed but mortality rates associated with surgery may be as high as 7-29% [8]. PDT has been used extensively in the management of esophageal diseases. 

Izbicki, J. R., Hosch, S. B., Pichlmeier, U., Rehders, A., Busch, C., Niendorf, A., et al.. Prognostic value of iimnunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N. Engl. J. Med. 337, 1188-1194 (1997). 

SenzerNetfll. (2006). Bi-modality induction ofTNFa neoadjuvant chemoradlotherapy and TNFerade in patients with locally advanced, resectable esophageal carcinoma. Mol Ther 13 (Suppl 1) SI 10. 

Treatment is resection with end-to-end esophageal anastomosis. Dilatation has a high incidence of esophageal perforation, especially in young children, and may be related to the length of the stricture and its transmural involvement (Newman and Bender 1997). The diameter of the lumen increases with age and growth of the patient, and with repeated dilatations, but will never be normal (Newman and Bender 1997). Some patients will benefit from initial dilatation, but most ultimately require surgery (Amae et al. 2003). 

H. Inoue, N. Fukami, T. Yoshida, S.E. Kudo, Endoscopic mucosal resection for esophageal and gastric cancers, J. Gastroenterol. Hepatol. 17 (2002) 382-388. 

---